Literature DB >> 24648376

Redefining the surface anatomy of the saphenofemoral junction in vivo.

S Ali Mirjalili1, Jill C Muirhead, Mark D Stringer.   

Abstract

The surface anatomy of the saphenofemoral junction (SFJ) is especially relevant to surgeons. It is variably described in contemporary anatomy and clinical texts but is usually stated to lie 2.5-4 cm below and lateral to the pubic tubercle. The aim of this study was to map the SFJ accurately in healthy adults using ultrasound. One hundred healthy adults (mean age 27 years; 64 men) were scanned by an experienced sonographer using a 13-5 MHz linear probe. The center of the SFJ was recorded bilaterally in relation to the most superficial point of the pubic tubercle. The SFJ was readily identified in all participants. Its center was a mean of 2.4 ± 0.6 cm lateral (range 1-4.5 cm) and 1 ± 0.9 cm inferior to the pubic tubercle (range 2.5 above to 4 cm caudal to it). The junction was inferior to the pubic tubercle in 90% of lower limbs and at or above that level in 10%. In men, the SFJ was a mean of 2.6 cm lateral to the pubic tubercle and 1.2 cm inferior to it, compared with 2.2 and 0.6 cm, respectively, in women (P < 0.001). The SFJ was also slightly nearer the pubic tubercle in younger and thinner participants (P < 0.01). The center of the SFJ lies in a square extending 1-4 cm lateral and up to 3 cm below the pubic tubercle in >90% of adults. The junction is slightly closer to the pubic tubercle in women. These results provide a more robust guide to the surface anatomy of the normal SFJ.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  saphenofemoral junction; surface anatomy; varicose veins

Mesh:

Year:  2014        PMID: 24648376     DOI: 10.1002/ca.22386

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  1 in total

1.  Cross-sectional area of the femoral vein varies with leg position and distance from the inguinal ligament.

Authors:  Dorota Czyzewska; Andrzej Ustymowicz; Radoslaw Kowalewski; Anna Zurada; Jaroslaw Krejza
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.